skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy
Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy

Petersson, J ; Giske, C G ; Eliasson, E

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
2
Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients

Petersson, J. ; Giske, C. G. ; Eliasson, E.

Acta anaesthesiologica Scandinavica, 2016-11, Vol.60 (10), p.1425-1436 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels
Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Kurland, S ; Furebring, M ; Löwdin, E ; Eliasson, E ; Nielsen, E I ; Sjölin, J

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
4
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

He, W. ; Eriksson, M. ; Eliasson, E. ; Grassmann, F. ; Bäcklund, M. ; Gabrielson, M. ; Hammarström, M. ; Margolin, S. ; Thorén, L. ; Wengström, Y. ; Borgquist, S. ; Hall, P. ; Czene, K.

Annals of oncology, 2021-10, Vol.32 (10), p.1286-1293 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
response of heterotrophic CO₂ flux to soil warming
response of heterotrophic CO₂ flux to soil warming
Material Type:
Artigo 		Adicionar ao Meu Espaço

response of heterotrophic CO₂ flux to soil warming

Eliasson, P.E ; McMurtrie, R.E ; Pepper, D.A ; Stromgren, M ; Linder, S ; Agren, G.I

Global change biology, 2005, Vol.11 (1), p.167-181 [Periódico revisado por pares]

Oxford, UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por
6
Drug–drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice
Drug–drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drug–drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice

Mannheimer, B. ; Eliasson, E.

Journal of internal medicine, 2010-12, Vol.268 (6), p.540-548 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
A Limited number of prescribed Drugs account for the majority of clinically relevant Drug interactions
A Limited number of prescribed Drugs account for the majority of clinically relevant Drug interactions
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Limited number of prescribed Drugs account for the majority of clinically relevant Drug interactions

Holm, J ; Eiermann, B ; Eliasson, E ; Mannheimer, B

CLINICAL THERAPEUTICS, 2015-08, Vol.37 (8), p.e100-e100 [Periódico revisado por pares]

Bridgewater: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Small gender differences in Drug concentrations stored in a TDM database
Small gender differences in Drug concentrations stored in a TDM database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Small gender differences in Drug concentrations stored in a TDM database

Sjöqvist, F ; Eliasson, E ; Lindh, J.D

Clinical therapeutics, 2015-08, Vol.37 (8), p.e105-e105 [Periódico revisado por pares]

Bridgewater: Elsevier Inc

Texto completo disponível

Citações Citado por
9
The Convergence of Conventional Therapeutic Drug Monitoring and Pharmacogenetic Testing in Personalized Medicine: Focus on Antidepressants
The Convergence of Conventional Therapeutic Drug Monitoring and Pharmacogenetic Testing in Personalized Medicine: Focus on Antidepressants
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Convergence of Conventional Therapeutic Drug Monitoring and Pharmacogenetic Testing in Personalized Medicine: Focus on Antidepressants

Sjöqvist, F ; Eliasson, E

Clinical pharmacology and therapeutics, 2007-06, Vol.81 (6), p.899-902 [Periódico revisado por pares]

New York, NY: Nature Publishing

Texto completo disponível

Citações Citado por
10
UGT1A43 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems
UGT1A43 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems
Material Type:
Artigo 		Adicionar ao Meu Espaço

UGT1A43 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems

Haslemo, T ; Loryan, I ; Ueda, N ; Mannheimer, B ; Bertilsson, L ; Ingelman-Sundberg, M ; Molden, E ; Eliasson, E

Clinical pharmacology and therapeutics, 2012-08, Vol.92 (2), p.221-227 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (701)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (744)
  2. Anais de Congresso  (57)
  3. Resenhas  (2)
  4. Book Chapters  (2)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1969  (38)
  2. 1969Até1982  (37)
  3. 1983Até1995  (104)
  4. 1996Até2009  (336)
  5. Após 2009  (292)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (785)
  2. Japonês  (107)
  3. Sueco  (13)
  4. Norueguês  (3)
  5. Espanhol  (2)
  6. Islândico  (2)
  7. Russo  (1)
  8. Francês  (1)
  9. Italiano  (1)
  10. Alemão  (1)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.